Non-steroidal anti-inflammatory drugs in Parkinson's disease
- 30 June 2007
- journal article
- review article
- Published by Elsevier BV in Experimental Neurology
- Vol. 205 (2), 295-312
- https://doi.org/10.1016/j.expneurol.2007.02.008
Abstract
No abstract availableKeywords
This publication has 183 references indexed in Scilit:
- Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's diseaseExperimental & Molecular Medicine, 2006
- Acetylsalicylic acid and acetaminophen protect against MPP+-induced mitochondrial damage and superoxide anion generationLife Sciences, 2006
- Differential regulation of cyclooxygenase-2 in the rat hippocampus after cerebral ischemia and ischemic toleranceNeuroscience Letters, 2006
- Lipid signaling: Sleep, synaptic plasticity, and neuroprotectionProstaglandins & Other Lipid Mediators, 2005
- Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microgliaNeuroscience Letters, 2005
- Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidationJournal of Neuroscience Research, 1998
- Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatumNeuroscience Letters, 1998
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+Journal of Neural Transmission, 1988
- Time course of nigrostriatal degeneration in parkinson's diseaseJournal of Neural Transmission, 1976